SHREE GANESH REMEDIES
Back to Cashflow Statement
|
SHREE GANESH REMEDIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹31 Cr | ₹30 Cr | ₹4.59 Cr | ₹-5.22 Cr |
What is the latest Cash Flow from Operating Activities ratio of SHREE GANESH REMEDIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹31 Cr |
| Mar2024 | ₹30 Cr |
| Mar2020 | ₹4.59 Cr |
| Mar2019 | ₹-5.22 Cr |
How is Cash Flow from Operating Activities of SHREE GANESH REMEDIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹31 Cr | 0.71 | |
| Mar2024 | ₹30 Cr | 563.81 | |
| Mar2020 | ₹4.59 Cr | Positive | |
| Mar2019 | ₹-5.22 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹829.7 Cr | -3.8% | 15.8% | 12.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -3.8% |
15.8% |
12.1% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses